Clinical observations on safety and efficacy of oxycontin® administered by rectal route in treating cancer related pain

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2477-2478

  Li, Cheng Guang ^a   Huang, Xin En ^a   Li, Ying ^a   Lu, Yan Yan ^a  

^a JIANGSU CANCER HOSPITAL   (China)

Author keywords

Cancer pain; Efficacy; Oxycontin ; Rectal route; Safety

Indexed keywords

EID: 84863276549     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Beaver WT, Wallenstein SL, Houde R, et al (1978). Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. J Pharmacol Exp Ther, 207, 101-8.
2. Beaver WT, Wallenstein SL, Rogers A, et al (1978). Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone. J Pharmacol Exp Ther, 207, 92-100.
3. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl, 3, S1-226.
4. Costantini M, Ripamonti C, Beccaro M, et al (2009). Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients' life. Results of an Italian mortality follow-back survey. Ann Oncol, 20, 729-35.
5. Dunlop RJ (1992). Managing cancer pain. Curr Ther, 33, 33-7.
6. Foley KM (2004). Acute and chronic cancer pain syndromes. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford Textbook of Palliative Medicine. 3rd ed. Oxford, UK. Oxford University Press, 299-316.
7. Glare PA, Walsh TD (1993). Dose-ranging study of oxycodone for chronic pain in advanced cancer. J Clin Oncol, 11, 973-8.
8. Kaba H, Fukuda H, Yamamoto S, et al (2004). Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0. Gan To Kagaku Ryoho, 31, 1187-92.
9. Korttila K, Pentti OM, Auvinen J (1980). Comparison of IM lysine acetylsalicylate and oxycodone in the treatment of pain after operation. Br J Anaesth, 52, 613-7.
10. Kalso E, Poyhia R, Onnela I' et al (1991). Intravenous morphine and oxycodone for pain after abdominal surgery. Acta Anaesthesiol Stand, 35, 642-6.
11. Kalso E, Vainio A (1990). Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther, 47, 639-46.
12. Kalso E, Vainio A, Mattila MJ et al (1990). Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays. Pharmacol Toxicol, 67, 322-8.
13. Leow KP, Cramond T, Smith MT (1995). Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesth Analg, 80, 296-302.
14. Leow KP, Smith MT, Williams B et al (1992). Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxy- codone in patients with cancer. Clin Pharmacol Ther, 52, 487-95.
15. Morrison JD, Loan WB, Dundee JW (1971). Controlled comparison of the efficacy of fourteen preparations in the relief of postopera- tive pain. BMJ, 3, 287-90.
16. Nuutinen LS, Wuolijoki E, Pentikainen IT (1986). Diclofenac and oxy- codone in treatment of postoperative pain: a double-blind trial. Acta Anaesthesiol Stand, 30, 620-4.
17. Stathers DN, Hunnybun J (1963). Oxycodone suppositories in the relief of intractable pain. Practitioner, 190, 779-81.
18. Takki S, Tammisto T (1973). A comparison of pethidine, pritiramide and oxycodone in patients with pain following cholecystectomy. Anaesthetist, 43, 44-53.
19. Twycross RG (1989). The management of pain in cancer. In: Nimmo WS, Smith G, eds. Anaesthesia. Oxford: Blackwell Scientific Publications, 1216-29.